Cargando…
Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211472/ https://www.ncbi.nlm.nih.gov/pubmed/30382863 http://dx.doi.org/10.1186/s13054-018-2231-6 |
_version_ | 1783367340607406080 |
---|---|
author | Honore, Patrick M. De Bels, David Gutierrez, Leonel Barreto Redant, Sebastien Attou, Rachid Gallerani, Andrea Spapen, Herbert D. |
author_facet | Honore, Patrick M. De Bels, David Gutierrez, Leonel Barreto Redant, Sebastien Attou, Rachid Gallerani, Andrea Spapen, Herbert D. |
author_sort | Honore, Patrick M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6211472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62114722018-11-08 Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? Honore, Patrick M. De Bels, David Gutierrez, Leonel Barreto Redant, Sebastien Attou, Rachid Gallerani, Andrea Spapen, Herbert D. Crit Care Letter BioMed Central 2018-11-01 /pmc/articles/PMC6211472/ /pubmed/30382863 http://dx.doi.org/10.1186/s13054-018-2231-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter Honore, Patrick M. De Bels, David Gutierrez, Leonel Barreto Redant, Sebastien Attou, Rachid Gallerani, Andrea Spapen, Herbert D. Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? |
title | Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? |
title_full | Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? |
title_fullStr | Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? |
title_full_unstemmed | Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? |
title_short | Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? |
title_sort | optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211472/ https://www.ncbi.nlm.nih.gov/pubmed/30382863 http://dx.doi.org/10.1186/s13054-018-2231-6 |
work_keys_str_mv | AT honorepatrickm optimizingmicafungindosingincriticallyillpatientswhataboutextracorporealtherapies AT debelsdavid optimizingmicafungindosingincriticallyillpatientswhataboutextracorporealtherapies AT gutierrezleonelbarreto optimizingmicafungindosingincriticallyillpatientswhataboutextracorporealtherapies AT redantsebastien optimizingmicafungindosingincriticallyillpatientswhataboutextracorporealtherapies AT attourachid optimizingmicafungindosingincriticallyillpatientswhataboutextracorporealtherapies AT galleraniandrea optimizingmicafungindosingincriticallyillpatientswhataboutextracorporealtherapies AT spapenherbertd optimizingmicafungindosingincriticallyillpatientswhataboutextracorporealtherapies |